ELTP - ($0.28) Elite Pharmaceuticals Analyst Report offers Insight and Market Data by BrokerBank Securities, Inc. ref. http://www.bizjournals.com/buffalo/prnewswire/press_releases/New_York/2014/02/10/DE61738